| Primary |
| Narcolepsy |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
| Stress |
50.0% |
| Wound Drainage |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
36.6% |
| Depression |
9.9% |
| Bipolar Disorder |
8.4% |
| Drug Use For Unknown Indication |
6.8% |
| Fibromyalgia |
4.7% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Asthma |
2.6% |
| Psychotic Disorder |
2.6% |
| Restless Legs Syndrome |
2.6% |
| Completed Suicide |
2.1% |
| Hypertension |
2.1% |
| Migraine |
2.1% |
| Oesophagitis |
2.1% |
| Pain |
2.1% |
| Diabetes Mellitus |
1.6% |
| Liver Transplant |
1.6% |
| Neuropathy Peripheral |
1.6% |
| Renal Transplant |
1.6% |
| Rheumatoid Arthritis |
1.6% |
|
| Necrosis |
13.6% |
| Pain |
9.1% |
| Drug Abuse |
6.8% |
| Weight Increased |
6.8% |
| Drug Ineffective |
4.5% |
| Drug Interaction |
4.5% |
| Headache |
4.5% |
| Malaise |
4.5% |
| Nausea |
4.5% |
| Overdose |
4.5% |
| Somnolence |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Suicidal Ideation |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Vision Blurred |
4.5% |
| Visual Impairment |
4.5% |
| Alcohol Use |
2.3% |
| Anaphylactic Shock |
2.3% |
| Constipation |
2.3% |
| Deafness |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.8% |
| Drug Use For Unknown Indication |
17.2% |
| Multiple Sclerosis |
16.6% |
| Hypertension |
6.4% |
| Pain |
5.0% |
| Rheumatoid Arthritis |
4.8% |
| Back Pain |
4.7% |
| Depression |
3.4% |
| Asthma |
3.2% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Atrial Fibrillation |
1.9% |
| Bipolar Disorder |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Anxiety |
1.7% |
| Diabetes Mellitus |
1.6% |
| Osteoporosis |
1.6% |
| Crohn's Disease |
1.5% |
| Obesity |
1.5% |
| Arthritis |
1.3% |
| Ex-tobacco User |
1.2% |
|
| Wrong Technique In Drug Usage Process |
25.3% |
| Weight Decreased |
8.9% |
| Death |
6.1% |
| Vomiting |
5.8% |
| Drug Ineffective |
4.8% |
| Pneumonia |
4.8% |
| Rash |
4.4% |
| Urinary Tract Infection |
4.4% |
| Tremor |
3.8% |
| Weight Increased |
3.8% |
| Injection Site Erythema |
3.4% |
| Product Quality Issue |
3.1% |
| Respiratory Failure |
3.1% |
| Flushing |
2.7% |
| Multiple Sclerosis Relapse |
2.7% |
| Myocardial Infarction |
2.7% |
| Renal Failure |
2.7% |
| Withdrawal Syndrome |
2.7% |
| Convulsion |
2.4% |
| Fall |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
37.5% |
| Hiv Infection |
25.0% |
| Insomnia |
12.5% |
| Liver Transplant |
12.5% |
| Pain |
12.5% |
|
| Dysuria |
25.0% |
| Virologic Failure |
25.0% |
| Vision Blurred |
25.0% |
| Yellow Skin |
25.0% |
|
